INTERNATIONAL PATENT: ULTRAGENYX PHARMACEUTICAL INC. FILES APPLICATION FOR "DOSING REGIMENS FOR ANTISENSE TREATMENT OF ANGELMAN SYNDROME"

GENEVA, Oct. 20 -- ULTRAGENYX PHARMACEUTICAL INC. (60 Leveroni CourtNovato, California 94949) filed a patent application (PCT/US2025/024175) for "DOSING REGIMENS FOR ANTISENSE TREATMENT OF ANGELMAN SYNDROME" on Apr 10, 2025. With publication no. WO/2025/217466, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): OLUGEMO, Olukemi Ajayi (c/o Ultragenyx Pharmaceutical Inc.60 Leveroni CourtNovato, California 94949), SKRINAR, Alison Mallinger (c/o Ultragenyx Pharmaceutical Inc.60 Leveroni CourtNovato, California 94949), KAKKIS, Em...